Sunday, May 15, 2022
AlloVir (NASDAQ: ALVR) Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Posoleucel, Treatment of Life-Threatening Infections in Allogeneic Hematopoietic Cell Transplant Patients
AlloVir, Inc. (NASDAQ: ALVR) is a late-stage clinical cell therapy company, which is focused on the research, development and commercialization...
Read more
Checkmate Pharmaceuticals (NASDAQ: CMPI) Skyrockets 333% After Agreement to be Acquired by Regeneron (NASDAQ: REGN) for $250 Million
Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) is engaged as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology...
Read more
LIXTE Biotechnology (NASDAQ: LIXT) Releases Preclinical Results of Cancer Treatment LB-100 Showing Strong Anti-Cancer Activity with Novel Drug Combinations
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) is engaged as a clinical-stage pharmaceutical company, which is focused on the research, development...
Read more
Veru (NASDAQ: VERU) Reports Novel COVID-19 Drug Candidate Able to Reduce Deaths by 55% in Hospitalized Patients During Phase 3 Study’s Interim Analysis
Veru, Inc. (NASDAQ: VERU) is engaged as an oncology-focused biopharmaceutical company, which specializes in novel treatments for breast and prostate...
Read more
Hoth Therapeutics (NASDAQ: HOTH) Reports its HT-KIT Novel Therapeutic Able to Block and Kill Cancer Cell Growth over 72 Hours, Orphan Drug Status Granted
Hoth Therapeutics, Inc. (NASDAQ: HOTH) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development, and...
Read more
Trevi Therapeutics (NASDAQ: TRVI) Announces At-the-Market Private Placement Seeking Gross Proceeds of $55 Million
Trevi Therapeutics, Inc. (NASDAQ: TRVI) operates as a clinical-stage biopharmaceutical company, which is focused on the research, development and commercialization ...
Read more
Sunshine Biopharma (NASDAQ: SBFM) Reports Its New mRNA Treatment Able to Treat Multidrug Resistant Cancer Cells
Sunshine Biopharma, Inc. (NASDAQ: SBFM) is engaged as a pharmaceutical company, which is focused on the discovery, research, development, and...
Read more
Clovis Oncology (NASDAQ: CLVS) Completes Phase 3 ATHENA-MONO Trial of Rubraca Showing Significance as a Maintenance Treatment in Women with Ovarian Cancer
Clovis Oncology, Inc. (NASDAQ: CLVS) is engaged as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization...
Read more
Ovid Therapeutics (NASDAQ: OVID): An Undervalued Biotech Company Firing Up the Revenue Engines
Microcap biotech investing certainly is not for the faint of heart, as the space can yield outsized rewards for investors...
Read more
NeuroSense Therapeutics (NASDAQ: NRSN) Set to Begin In-Human Trials for ALS Treatment PrimeC After FDA Clearance
NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN) is engaged as a clinical-stage biotechnology company, which is focused on the research and development...
Read more
